The growing preferences for customized medicine and growing preference for a healthy lifestyle are the foremost aspects accountable for propelling the growth of the western blotting market. In addition, the introduction of improved diagnostic technologies and great awareness, and the increasing prevalence of diseases also heighten the market’s complete growth. The economic, speedy diagnostic treatment by the western blotting processors is projected to foster the complete demand for the product.
Aspects such as the growing global burden of chronic diseases, increasing research activities in the biotech and pharma segment, and augmented research & development investment by pharmaceutical and biotechnology businesses are propelling the western blotting market. Over the review duration, the global western blotting market is projected to augment owing to the increasing prevalence of HIV/AIDS. Based on the Joint United Nations Program on HIV/AIDS predicted that 37.9 million individuals around the globe were living with HIV at the end of 2018. Nonetheless, growing applications of the western blotting approaches are probable to propel the market growth.
According to the SPER market research, ‘Western Blotting Market Size, Share & Trends Analysis By Product, By Applications, By End Users, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030’ states the Western Blotting Market to reach USD 1.6 billion by 2030 with a CAGR of 5.9%. The prevalence of HIV/AIDS around the globe, augment funding in the biomedical segment, and moving towards customized medicine, and technological innovations, are the growth aspects propelling aspects.
Augment in scientific & research activities has substantially fostered the requirement for western blotting products during the past years. With the augment in demand for several types of electrophoresis blotting systems likewise automated dry blotting systems, and semi-dry blotting systems, to name a few, producers are also emphasizing launching a broader variety of products.
Request For Free Sample Report https://www.sperresearch.com/report-store/Western-Blotting.aspx?sample=1
Although, the Western blot test is having a broad variety of applications in medical diagnostics. For the diagnosis of diseases such as BSE (Bovine Spongiform Encephalopathy), HBV (Hepatitis B Virus) infection, FIV (Feline Immunodeficiency Virus), and Lyme Disease among others. Commonly, this test is utilized as a confirmatory test for the above-cited diseases after the ELISA test is done with a positive result. For Lyme Disease, the United States Food and Drug Administration has proposed the two-tier protocol utilizing an ELISA test initially and then the precise western blot tests for the confirmation of diagnosis if the results of ELISA are positive. Previously, western blotting was commonly done to check the HIV diagnosis.
The growing prevalence of HIV, Lyme disease, and hepatitis are foremost fuelling aspects for the market growth. For instance, as per the 2021 update from Global HIV & AIDS statistics, 38+ million individuals around the globe were living with HIV in 2021. Moreover, more than 1 million individuals became newly infected with HIV in 2021. A greater prevalence of such diseases causes more diagnostic tests and thus fosters market growth.
Moreover, product launches and approvals are primarily implemented strategies by companies to enlarge their international footprints and product portfolios. The western blotting market players aim at the partnership strategy to enlarge their clientele, which, in turn, permits them to manage their brand name around the globe. The market is projected to flourish during the forthcoming years owing to the advancement of innovative products by market players.
For More Information, refer to below link: -
Global Western Blotting Market Size,
Related Reports:
Follow Us –
LinkedIn | Instagram | Facebook | Twitter
Contact Us:
Sara Lopes, Business Consultant – USA
SPER Market Research
+1-347-460-2899
In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region.
This can be attributed to increasing government interest in biomedical & biotechnology industry in China, government initiatives supported by funding in Japan, growing funding for agriculture research in India, increasing diagnosis and related funding in Australia, and growing prevalence of herpes simplex virus (HSV) in southeast Asia.Major Growth Drivers:The growth of the overall market can be attributed to the increasing number of research activities and R spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, and growing proteomics market are key factors driving the demand for western blotting instruments and consumables, increasing demand for personalized medicine, and new product launches are some of the other factors driving the growth of this market.Expected Revenue Growth:The western blotting market is projected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021).Accessories to Fuel the Growth of Western Blotting Market :The western blotting market, by product is segmented into instruments and consumables.
Consumables segment is expected to account for the largest share of the market, by product in 2016.
This segment is also expected to grow at the highest CAGR during the forecast period.
The western blotting instruments are further classified into gel electrophoresis instruments, blotting systems, and imagers.
The blotting systems segment is expected to account for the largest share of western blotting instruments market, by type in 2016.
